Joshua M. Eizen

Companies

• AN2 Therapeutics, Inc.Officer Oct 5, 2022 to now¹
• AN2 Therapeutics, Inc.General counsel Oct 28, 2022 to Jul 12, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAN2 Therapeutics, Inc. ANTX206,554 shares³$675.4K at $3.27Jul 8, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 8, 2026Sold 5,945 shares at $4.17 of AN2 Therapeutics, Inc.³
• Feb 20, 2026Granted 50,000 shares of AN2 Therapeutics, Inc.⁴
• Jan 6, 2026Sold 6,931 shares at $1.01 of AN2 Therapeutics, Inc.⁵
• Jan 5, 2026Sold 17,923 shares at $1.00 of AN2 Therapeutics, Inc.⁵
• Nov 4, 2025Sold 2,819 shares at $1.14 of AN2 Therapeutics, Inc.⁶
• Feb 26, 2025Granted 58,500 shares of AN2 Therapeutics, Inc.⁷
• Jan 3, 2025Sold 9,663 shares at $1.34 of AN2 Therapeutics, Inc.⁸
• Nov 4, 2024Granted 31,500 shares of AN2 Therapeutics, Inc.⁹
• Jul 10, 2024Granted 60,000 shares of AN2 Therapeutics, Inc.¹⁰
• Mar 15, 2024Granted 30,000 shares of AN2 Therapeutics, Inc.¹¹
• Mar 15, 2024Granted 30,000 shares of AN2 Therapeutics, Inc.¹²